title: Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
abstract: Previous studies have shown that allelic losses in a locus mapping to the chromosomal region 4p14-16 are indicative of poor prognosis in colorectal cancer. To further characterize the region involved and to confirm earlier observations, we have analyzed losses of heterozygosity (LOH) in nine microsatellite markers spanning this region in a prospective series of 181 colorectal carcinomas. The extent and the nature of the allelic imbalance were also ascertained by comparative genomic hybridization analysis of selected cases. The minimum common deleted region was confined to marker D4S2397 (LOH in 35% of the informative cases). Surrounding markers displayed LOH in 13-25% of informative cases and (other than the D4S2397 marker itself) showed a higher rate of allelic imbalances in association with mutations in the p53 tumor suppressor gene. Tumors with lymph node invasion also displayed increased rates of LOH in most markers. Regarding patient outcome, LOH solely at the D4S2397 locus was indicative of a shorter disease-free survival (P = 0.027). In consequence, two patterns of allelic loss are defined within the 4p14-16 region: (a) gross losses associated with tumor progression and probably attributable to the genomic instability related to the inactivation of the p53 tumor suppressor gene; and (b) specific losses limited to the D4S2397 locus (within an estimated fragment of 2 Mb) and associated with increased tumor aggressiveness. The presence of one or more putative tumor suppressor genes in this region is postulated.
authors.affiliation: Institut de Recerca Oncològica, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Arribas
authors.forename: M
authors.initials: M
authors.lastname: Ribas
authors.forename: R A
authors.initials: RA
authors.lastname: Risques
authors.forename: L
authors.initials: L
authors.lastname: Masramon
authors.forename: S
authors.initials: S
authors.lastname: Tórtola
authors.forename: E
authors.initials: E
authors.lastname: Marcuello
authors.forename: G
authors.initials: G
authors.lastname: Aiza
authors.forename: R
authors.initials: R
authors.lastname: Miró
authors.forename: G
authors.initials: G
authors.lastname: Capellà
authors.forename: M A
authors.initials: MA
authors.lastname: Peinado
mesh_terms: D000483:Alleles; D002874:Chromosome Mapping; D002894:Chromosomes, Human, Pair 4; D003062:Codon; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D016158:Genes, p53; D011905:Genes, ras; D005819:Genetic Markers; D006801:Humans; D019656:Loss of Heterozygosity; D008207:Lymphatic Metastasis; D018895:Microsatellite Repeats; D011237:Predictive Value of Tests; D011379:Prognosis; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
chemical_list: D003062:Codon; D005819:Genetic Markers